Markets:

Overview

News

Currencies

International

Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

1.430 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about bioAffinity Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

November 14, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

November 06, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference

October 10, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 04, 2023

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 21, 2023

Via Benzinga

bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

September 19, 2023

From bioAffinity Technologies

Via Business Wire

bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference

September 07, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update

August 14, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer

July 12, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium

June 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 06, 2023

Via Benzinga

bioAffinity Technologies Presents Research Findings at CYTO 2023

May 22, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports First Quarter 2023 Financial Results

May 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer

May 01, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium

April 25, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Ring Nasdaq Closing Bell Today

April 05, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results

March 31, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer

March 28, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023

March 24, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 14, 2023

Via Benzinga

bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications

February 13, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Dow Rises 80 Points; Altamira Therapeutics Shares Plunge ↗

January 24, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500...

Via Benzinga

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 24, 2023

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 24, 2023

Via Benzinga

Dow Edges Higher; Crude Oil Down 1% ↗

January 24, 2023

U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday. The Dow traded up 0.03% to 33,638.42 while the NASDAQ fell 0.07% to 11,356.65. The S&P 500...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 24, 2023

Via Benzinga

bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research

January 24, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments

January 04, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

All News about bioAffinity Technologies, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today